Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297187 · ClinicalTrials.gov registry record
Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
A clinical trial of Condylomata Acuminata and Vulvar Intraepithelial Neoplasia, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 56
- Enrollment target
- 1
- Study location
NCT06297187 is a study of Condylomata Acuminata and Vulvar Intraepithelial Neoplasia that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 56 participants, below the 162-participant average among 3 other Condylomata Acuminata trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06297187, a study of Condylomata Acuminata and Vulvar Intraepithelial Neoplasia, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a single arm, retrospective, single-center, post market registry. The purpose of this Registry is to collect data to demonstrate the safety and performance of CUSA® for the treatment of Vulvar Intraepithelial Neoplasia (VIN) and condyloma acuminata.
Conditions Studied
Interventions
- DEVICE CUSA (Cavitronic Ultrasonic Surgical Aspirator)
Study Locations (1)
Texas
- The Center for Cancer and Blood Disorders - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-02-23 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06297187
The ClinicalTrials.gov registry entry for NCT06297187 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 3 other Condylomata Acuminata trials with a reported enrollment target (65% lower). The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Condylomata Acuminata appearing as the primary indexed condition, and to 1 intervention - of which CUSA (Cavitronic Ultrasonic Surgical Aspirator) is the first listed.
NCT06297187 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06297187 about?
NCT06297187 is a clinical study titled "Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study". The study is a single arm, retrospective, single-center, post market registry. The purpose of this Registry is to collect data to demonstrate the safety and performance of CUSA® for the treatment of Vulvar Intraepithelial Neoplasia (VIN) and condyloma acuminata.
What is the current status of trial NCT06297187?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2024-02-23. Estimated completion is 2024-08-31.
What conditions does trial NCT06297187 study?
This clinical trial studies the following conditions: Condylomata Acuminata, Vulvar Intraepithelial Neoplasia.
What interventions are being tested in trial NCT06297187?
The interventions under investigation include: CUSA (Cavitronic Ultrasonic Surgical Aspirator) (DEVICE).
Who is sponsoring clinical trial NCT06297187?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297187 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Condylomata Acuminata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.